Share on LinkedInShare on LinkedIn

ARTICLE · 06 MARCH 2021

Localization Of Imported Products

Gün + Partners
Gün + Partners
Contributor
Gün + Partners

Gün + Partners

We are one of the oldest and largest law firms in Turkey and are considered internationally to be...

View firm profile
Explore more from Gün + Partners

Following the announcement of the Structural Transformation Program Action Plan for Healthcare Industries on 7 November 2014, Turkey commenced adopting measures to ...

TurkeyInternational Law
Gün + Partners
Gün + Partners
Author LinkedIn connections

Following the announcement of the Structural Transformation Program Action Plan for Healthcare Industries on 7 November 2014, Turkey commenced adopting measures to localize the production of a substantial number of pharmaceutical products sold in Turkey. On 10 December 2015, the 64th Government announced the 2016 Action Plan (64th Government Action Plan), which included a statement that measures would be taken to prioritize domestically produced medical supplies and medical devices. This statement, "Import products to be removed from the reimbursement list will be identified provided that the provision of medical treatment is duly guaranteed," in the 2016 Action Plan implies that imported products with a locally produced equivalence will be delisted from the reimbursement list.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Register for freeORLog in

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

View source

Related Articles

Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics

Read more about

See more popular content from

Article

WTO Is Reshaping Turkish Automotive Industry: What You Need To Know

In April 2024, we wrote about Turkey's newly introduced regulatory framework for electric vehicle ("EV") imports and questioned whether a regime requiring certain importers to establish their own (not through any third parties) service networks, operate a forty-person call centre and comply with additional certification and representation requirements could be reconciled with Turkey's international trade obligations1.
TurkeyInternational Law
Balcioglu Selçuk Eymirlioglu Ardiyok Keki Attorney Partnership
Balcioglu Selçuk Eymirlioglu Ardiyok Keki Attorney Partnership
Article

Enforcement Of Russian Court Decisions And Arbitral Awards In Türkiye: A New Era

The geopolitical shifts in recent years drastically changed the landscape of international dispute resolution. Today, finding legal representation and navigating the dispute itself are only the initial hurdles; winning a case on the merits is no longer the finish line. The real challenge—and the ultimate battleground—is successfully enforcing those judgments and arbitral awards abroad.
TurkeyInternational Law
Baysal & Demir
Baysal & Demir
Article

Turkey’s NGGS Filing Calendar For Anti-Dumping And Countervailing Measures Expiring In 2027

Communiqué No. 2026/28 on the Prevention of Unfair Competition in Imports, published in Official Gazette No. 33340 dated 14 August 2026 (the “Communiqué”), announced eleven anti-dumping and countervailing measures whose periods of application will expire during the first half of 2027. Unless an expiry review investigation, known in Turkish as a nihai gözden geçirme soruşturması (“NGGS”), is opened in respect of them, those measures will expire between 15 January and 14 June 2027.
TurkeyInternational Law
ASY Legal
ASY Legal
Article

Data Protection And Privacy Law In Türkiye Key Developments And Predictions - 2026

This comprehensive report examines the evolving landscape of personal data protection in Türkiye, analyzing regulatory developments, enforcement trends, and emerging compliance challenges through 2025 and into the first half of 2026. The analysis covers the Turkish Personal Data Protection Authority's expanding guidance framework, significant enforcement actions totaling TRY 352.5 million in fines, and critical regulatory shifts including new cybersecurity legislation and constitutional court decisions
TurkeyPrivacy
Gün + Partners
Gün + Partners
Article

New Pricing Communiqué Following The New Pricing Decision For Medicinal Products For Human Use: Increase Of The Euro Conversion Rate To 65% Of The Previous Year’s Average And Details Of The Pricing Incentive For The First Equivalent/Generic Product

Turkey's pharmaceutical pricing system undergoes a major restructuring with the publication of the New Pricing Communiqué on August 29, 2026, implementing significant changes including increased Euro/TRY conversion rates, incentive mechanisms for first generic market entry, and the introduction of value-based pricing concepts. The new regulations establish detailed provisions for special product categories while leaving certain implementation details to future secondary legislation.
TurkeyFood, Drugs, Healthcare, Life Sciences
Gün + Partners
Gün + Partners
Article

Copyright Law In TÜRKİYE Key Developments And Predictions - 2026

The rapidly evolving digital ecosystem has transformed copyright law from a technical field into a central topic of economic and societal debate. This comprehensive review examines significant developments in Turkish copyright law as of 2025, exploring how artificial intelligence, digital content creation, press publishing rights, and the sports industry are challenging existing legal frameworks and reshaping the balance between right holders and users.
TurkeyIntellectual Property
Gün + Partners
Gün + Partners